USRDS Period prevalent ESRD patient deaths ESRD expenditures

USRDS Costs of the ESRD & Medicare programs figure 12. 2, dollars in 2000

USRDS Percent change in allowable PMPM table 12. a, incident dialysis patients, 1999 USRDS

USRDS Relative costs: diabetic figure 12. 3, incident hemodialysis patients, 1999, adjusted USRDS 2002

USRDS Relative costs: non-diabetic figure 12. 3, incident hemodialysis patients, 1999, adjusted USRDS 2002

USRDS Relative costs: hemodialysis figure 12. 3, incident hemodialysis patients, 1999, adjusted USRDS 2002

USRDS Relative costs: peritoneal dialysis figure 12. 3, incident hemodialysis patients, 1999, adjusted USRDS

USRDS Relative costs: diabetic Part A figure 12. 4, incident hemodialysis patients, 1999, adjusted,

USRDS Relative costs: diabetic Part B figure 12. 4, incident hemodialysis patients, 1999, adjusted,

USRDS Relative costs: non-diabetic Part A figure 12. 4, incident hemodialysis patients, 1999, adjusted,

USRDS Relative costs: non-diabetic Part B figure 12. 4, incident hemodialysis patients, 1999, adjusted,

USRDS Unadjusted allowable per member per month (PMPM) costs: diabetic figure 12. 5, incident

USRDS Unadjusted allowable per member per month (PMPM) costs: non-diabetic figure 12. 5, incident

USRDS Unadjusted allowable per member per month (PMPM) costs: hemodialysis figure 12. 6, incident

USRDS Unadjusted allowable per member per month (PMPM) costs: peritoneal dialysis figure 12. 6,

USRDS Part A & Part B Medicare payments table 12. b, incident hemodialysis patients,

USRDS Patient characteristics: age figure 12. 7, incident ESRD patients, 1999 1 · All

USRDS Patient characteristics: gender figure 12. 7, incident ESRD patients, 1999 1 · All

USRDS Patient characteristics: race figure 12. 7, incident ESRD patients, 1999 1 · All

USRDS Patient characteristics: Hispanic ethnicity figure 12. 7, incident ESRD patients, 1999 1 ·

USRDS Patient characteristics: primary diagnosis figure 12. 7, incident ESRD patients, 1999 1 ·

USRDS Patient characteristics: diabetic status figure 12. 7, incident ESRD patients, 1999 1 ·

USRDS Medicare allowable PMPM net pay: total costs figure 12. 8, incident ESRD patients,

USRDS Medicare allowable PMPM net pay: Part A costs, diabetic figure 12. 9, incident

USRDS Medicare allowable PMPM net pay: Part A costs, non-diabetic figure 12. 9, incident

USRDS Medicare allowable PMPM net pay: Part B costs, diabetic figure 12. 10, incident

USRDS Medicare allowable PMPM net pay: Part B costs, non-diabetic figure 12. 10, incident

USRDS Medicare ESRD inpatient utilization hospitalizations table 12. c, per 100 patient years, period

USRDS Medicare ESRD inpatient utilization hospitalizations: age & gender figure 12. 11, per 100

USRDS Medicare ESRD inpatient utilization hospitalizations: race & primary diagnosis figure 12. 11, per

USRDS Trends in total expenditures & expenditures per patient year figure 12. 12, period

USRDS Change in total expenditures & subgroups, 1991– 2000: all patients figure 12. 13,

USRDS Change in total expenditures & subgroups, 1991– 2000: dialysis only figure 12. 13,

USRDS Change in total expenditures & subgroups, 1991– 2000: new transplant within the year

USRDS Change in total expenditures & subgroups, 1991– 2000: functioning graft figure 12. 13,

USRDS Change in total expenditures & subgroups, 1991– 2000: graft failure during the year

USRDS Change in expenditures per patient year, 1991– 2000: all patients figure 12. 14,

USRDS Change in expenditures per patient year, 1991– 2000: dialysis only figure 12. 14,

USRDS Change in expenditures per patient year, 1991– 2000: new transplant within the year

USRDS Change in expenditures per patient year, 1991– 2000: functioning graft figure 12. 14,

USRDS Change in expenditures per patient year, 1991– 2000: graft failure during the year

USRDS Trends in the Medicare risk population: ESRD risk patients figure 12. 15, period

USRDS Trends in the Medicare risk population: ESRD risk months figure 12. 15, period

USRDS Trends in the Medicare risk population: general Medicare risk patients figure 12. 15,

USRDS Percent of Medicare risk patients: 1990 figure 12. 16, ESRD patients enrolled in

USRDS Percent of Medicare risk patients: 1995 figure 12. 16, ESRD patients enrolled in

USRDS Percent of Medicare risk patients: 2000 figure 12. 16, ESRD patients enrolled in

USRDS Medicare risk patients: Modality distribution in HMO & non-HMO groups figure 12. 17,

USRDS Number of Medicare risk patients, by metropolitan statistical areas figure 12. 18, period

USRDS Percent of Medicare risk patients figure 12. 18, period prevalent ESRD patients, 2000,

USRDS Distribution of Medicare risk patients: ESRD network table 12. d, period prevalent ESRD

USRDS Distribution of Medicare risk patients: demographics table 12. d, period prevalent ESRD patients,

USRDS Characteristics of patients with Medicare risk coverage: incident patients figure 12. 19, ESRD

USRDS Percent of patients with Medicare risk coverage: incident patients figure 12. 19, ESRD

USRDS Percent of patients with Medicare risk coverage: prevalent patients figure 12. 20, ESRD

USRDS Per member per month (PMPM) costs: dialysis & EPO figure 12. 21, period

USRDS Per member per month (PMPM) costs: IV iron & vitamin D hormones figure

USRDS Per member per month (PMPM) costs: other injectables & laboratory figure 12. 21,

USRDS Per member per month (PMPM) costs: EPO & iron figure 12. 22, period

USRDS Per member per month (PMPM) costs: vitamin D hormones & other injectables figure

USRDS Per member per month (PMPM) costs: inpatient figure 12. 23, period prevalent dialysis

USRDS Per member per month (PMPM) costs: outpatient figure 12. 23, period prevalent dialysis

USRDS Per member per month (PMPM) Part A Costs: inpatient figure 12. 24, period

USRDS Per member per month (PMPM) Part A Costs: outpatient figure 12. 24, period

USRDS Per member per month (PMPM) Part A Costs: dialysis figure 12. 24 period

USRDS Per member per month (PMPM), Part B costs figure 12. 24, period prevalent

USRDS Part A relative costs: inpatient figure 12. 25, period prevalent patients, 2000, by

USRDS Part A relative costs: outpatient figure 12. 25, period prevalent patients, 2000, by

USRDS Part A relative costs: dialysis figure 12. 25, period prevalent patients, 2000, by

USRDS Part B relative costs figure 12. 25, period prevalent patients, 2000, by HSA,

USRDS Trends in total access procedures figure 12. 26, Medicare ESRD Part B vascular

USRDS Trends in access costs figure 12. 27, Medicare ESRD Part B vascular access

USRDS Trends in location of access procedures figure 12. 28, by setting, Medicare Part

USRDS Percent of procedures that are access only figure 12. 29 USRDS 2002 adr

USRDS Vascular access spending: dollars by intervention type & location of service figure 12.

USRDS Vascular access spending: dollars by access type & intervention figure 12. 31 USRDS

USRDS Vascular access spending: dollars by access type & physician specialty figure 12. 32

USRDS Fistula insertion costs per procedure: 1991 figure 12. 33, by state Cost per

USRDS Fistula insertion costs per procedure: 2000 figure 12. 33, by state Cost per

USRDS Fistula insertion costs per procedure: percent change 1991– 2000 figure 12. 33, by

USRDS Synthetic graft insertion costs per procedure: 1991 figure 12. 34, by state Cost

USRDS Synthetic graft insertion costs per procedure: 2000 figure 12. 34, by state Cost

USRDS Synthetic graft insertion costs per procedure: percent change 1991– 2000 figure 12. 34,

USRDS Catheter insertion costs per procedure: 1991 figure 12. 35, by state Cost per

USRDS Catheter insertion costs per procedure: 2000 figure 12. 35, by state Cost per

USRDS Catheter insertion costs per procedure: percent change 1991– 2000 figure 12. 35, by

USRDS Vascular access complications costs per event: 1991 figure 12. 36, by state Cost

USRDS Vascular access complications costs per event: 2000 figure 12. 36, by state Cost

USRDS Vascular access complications costs per event: percent change 1991– 2000 figure 12. 36,

Slides: 90

Download presentation

USRDS Period prevalent ESRD patient, deaths, & ESRD expenditures figure 12. 1 USRDS 2002 adr

USRDS Costs of the ESRD & Medicare programs figure 12. 2, dollars in 2000 are inflated by 2% to account for costs incurred not reported USRDS 2002 adr

USRDS Percent change in allowable PMPM table 12. a, incident dialysis patients, 1999 USRDS 2002 adr

USRDS Relative costs: diabetic figure 12. 3, incident hemodialysis patients, 1999, adjusted USRDS 2002 adr

USRDS Relative costs: non-diabetic figure 12. 3, incident hemodialysis patients, 1999, adjusted USRDS 2002 adr

USRDS Relative costs: hemodialysis figure 12. 3, incident hemodialysis patients, 1999, adjusted USRDS 2002 adr

USRDS Relative costs: peritoneal dialysis figure 12. 3, incident hemodialysis patients, 1999, adjusted USRDS 2002 adr

USRDS Relative costs: diabetic Part A figure 12. 4, incident hemodialysis patients, 1999, adjusted, reference population indicated by patterned bars USRDS 2002 adr

USRDS Relative costs: diabetic Part B figure 12. 4, incident hemodialysis patients, 1999, adjusted, reference population indicated by patterned bars USRDS 2002 adr

USRDS Relative costs: non-diabetic Part A figure 12. 4, incident hemodialysis patients, 1999, adjusted, reference population indicated by patterned bars USRDS 2002 adr

USRDS Relative costs: non-diabetic Part B figure 12. 4, incident hemodialysis patients, 1999, adjusted, reference population indicated by patterned bars USRDS 2002 adr

USRDS Unadjusted allowable per member per month (PMPM) costs: diabetic figure 12. 5, incident hemodialysis patients, 1999 USRDS 2002 adr

USRDS Unadjusted allowable per member per month (PMPM) costs: non-diabetic figure 12. 5, incident hemodialysis patients, 1999 USRDS 2002 adr

USRDS Unadjusted allowable per member per month (PMPM) costs: hemodialysis figure 12. 6, incident dialysis patients, 1999 USRDS 2002 adr

USRDS Unadjusted allowable per member per month (PMPM) costs: peritoneal dialysis figure 12. 6, incident dialysis patients, 1999 USRDS 2002 adr

USRDS Part A & Part B Medicare payments table 12. b, incident hemodialysis patients, 1999 USRDS 2002 adr

USRDS Patient characteristics: age figure 12. 7, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Patient characteristics: gender figure 12. 7, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Patient characteristics: race figure 12. 7, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Patient characteristics: Hispanic ethnicity figure 12. 7, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Patient characteristics: primary diagnosis figure 12. 7, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Patient characteristics: diabetic status figure 12. 7, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Medicare allowable PMPM net pay: total costs figure 12. 8, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Medicare allowable PMPM net pay: Part A costs, diabetic figure 12. 9, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Medicare allowable PMPM net pay: Part A costs, non-diabetic figure 12. 9, incident ESRD patients, 1999 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Medicare allowable PMPM net pay: Part B costs, diabetic figure 12. 10, incident ESRD patients, 1999, by diabetic status 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Medicare allowable PMPM net pay: Part B costs, non-diabetic figure 12. 10, incident ESRD patients, 1999, by diabetic status 1 · All 2 · Medicaid only 3 · Medicare only 4 · Medicare with other 5 · Medicare & Medicaid 6 · Medicare & EGHP 7 · DVA or other 8 · EGHP only 9 · None USRDS 2002 adr

USRDS Medicare ESRD inpatient utilization hospitalizations table 12. c, per 100 patient years, period prevalent dialysis patients USRDS 2002 adr

USRDS Medicare ESRD inpatient utilization hospitalizations: age & gender figure 12. 11, per 100 patient years, period prevalent dialysis patients USRDS 2002 adr

USRDS Medicare ESRD inpatient utilization hospitalizations: race & primary diagnosis figure 12. 11, per 100 patient years, period prevalent dialysis patients USRDS 2002 adr

USRDS Trends in total expenditures & expenditures per patient year figure 12. 12, period prevalent ESRD patients USRDS 2002 adr

USRDS Change in total expenditures & subgroups, 1991– 2000: all patients figure 12. 13, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in total expenditures & subgroups, 1991– 2000: dialysis only figure 12. 13, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in total expenditures & subgroups, 1991– 2000: new transplant within the year figure 12. 13, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in total expenditures & subgroups, 1991– 2000: functioning graft figure 12. 13, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in total expenditures & subgroups, 1991– 2000: graft failure during the year figure 12. 13, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in expenditures per patient year, 1991– 2000: all patients figure 12. 14, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in expenditures per patient year, 1991– 2000: dialysis only figure 12. 14, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in expenditures per patient year, 1991– 2000: new transplant within the year figure 12. 14, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in expenditures per patient year, 1991– 2000: functioning graft figure 12. 14, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Change in expenditures per patient year, 1991– 2000: graft failure during the year figure 12. 14, period prevalent ESRD patients Pts · Total patients Total · Total expenditures IP · Inpatient OP · Outpatient SN · Skilled nursing HH · Home health HS · Hospice PS · Physician/supplier USRDS 2002 adr

USRDS Trends in the Medicare risk population: ESRD risk patients figure 12. 15, period prevalent patients in each year USRDS 2002 adr

USRDS Trends in the Medicare risk population: ESRD risk months figure 12. 15, period prevalent patients in each year USRDS 2002 adr

USRDS Trends in the Medicare risk population: general Medicare risk patients figure 12. 15, period prevalent patients in each year USRDS 2002 adr

USRDS Percent of Medicare risk patients: 1990 figure 12. 16, ESRD patients enrolled in Medicare + Choice managed care organizations Percent of patients 6. 34+ (7. 66) 1. 87 to <6. 34 1. 00 to <1. 87 0. 31 to <1. 00 below 0. 31 (0. 10) USRDS 2002 adr

USRDS Percent of Medicare risk patients: 1995 figure 12. 16, ESRD patients enrolled in Medicare + Choice managed care organizations Percent of patients 6. 34+ (9. 34) 1. 87 to <6. 34 1. 00 to <1. 87 0. 31 to <1. 00 below 0. 31 (0. 14) USRDS 2002 adr

USRDS Percent of Medicare risk patients: 2000 figure 12. 16, ESRD patients enrolled in Medicare + Choice managed care organizations Percent of patients 6. 34+ (11. 76) 1. 87 to <6. 34 1. 00 to <1. 87 0. 31 to <1. 00 below 0. 31 (0. 13) USRDS 2002 adr

USRDS Medicare risk patients: Modality distribution in HMO & non-HMO groups figure 12. 17, point prevalent ESRD patients on 1/1/2000 USRDS 2002 adr

USRDS Number of Medicare risk patients, by metropolitan statistical areas figure 12. 18, period prevalent ESRD patients, 2000 Metropolitan Statistical Areas (MSAs) with the greatest numbers of Medicare risk patients 1 -Los Angeles-Long Beach, CA 2 -New York, NY 3 -Philadelphia, PA 4 -Riverside-San Bernardino, CA 5 -Oakland, CA 6 -Chicago, IL 7 -Miami, FL 8 -Phoenix, AZ 9 -San Diego, CA 10 -San Francisco 11. Boston, MA 12. Ft. Lauderdale, FL 13. Orange County, CA 14. Pittsburgh, PA 15. Sacramento, CA 16. Denver, CO 17. Tampa-St. Petersburg, FL 18. Cleveland, OH 19. San Jose, CA 20. Houston, TX 21. Portland, OR 22. St. Louis, MO 23. Washington, DC 24. Palm Beach, FL 25. San Antonio, TX MSA (see table for details) USRDS 2002 adr

USRDS Percent of Medicare risk patients figure 12. 18, period prevalent ESRD patients, 2000, by MSA & HSA, unadjusted Percent of patients 3. 43+ (9. 03) 0. 67 to <3. 43 0. 27 to <0. 67 0. 11 to <0. 27 below 0. 11 (0. 06) USRDS 2002 adr

USRDS Distribution of Medicare risk patients: ESRD network table 12. d, period prevalent ESRD patients, 2000 USRDS 2002 adr

USRDS Distribution of Medicare risk patients: demographics table 12. d, period prevalent ESRD patients, 2000 USRDS 2002 adr

USRDS Characteristics of patients with Medicare risk coverage: incident patients figure 12. 19, ESRD patients, 2000, by age & gender USRDS 2002 adr

USRDS Percent of patients with Medicare risk coverage: incident patients figure 12. 19, ESRD patients, 2000, by race/ethnicity & primary diagnosis USRDS 2002 adr

USRDS Percent of patients with Medicare risk coverage: prevalent patients figure 12. 20, ESRD patients, 2000, by age & gender USRDS 2002 adr

USRDS Percent of patients with Medicare risk coverage: prevalent patients figure 12. 20, ESRD patients, 2000, by race/ethnicity & primary diagnosis USRDS 2002 adr

USRDS Per member per month (PMPM) costs: dialysis & EPO figure 12. 21, period prevalent patients All · All units Chain 5 · Dialysis Clinics, Inc. Chain 1 · Fresenius O · All other chain-affiliated units Chain 2 · Gambro NC · Non-chain units Chain 3 · Da. Vita HB · Hospital-based units Chain 4· Renal Care Group U · Unknown affiliation USRDS 2002 adr

USRDS Per member per month (PMPM) costs: IV iron & vitamin D hormones figure 12. 21, period prevalent patients All · All units Chain 5 · Dialysis Clinics, Inc. Chain 1 · Fresenius O · All other chain-affiliated units Chain 2 · Gambro NC · Non-chain units Chain 3 · Da. Vita HB · Hospital-based units Chain 4· Renal Care Group U · Unknown affiliation USRDS 2002 adr

USRDS Per member per month (PMPM) costs: other injectables & laboratory figure 12. 21, period prevalent patients All · All units Chain 5 · Dialysis Clinics, Inc. Chain 1 · Fresenius O · All other chain-affiliated units Chain 2 · Gambro NC · Non-chain units Chain 3 · Da. Vita HB · Hospital-based units Chain 4· Renal Care Group U · Unknown affiliation USRDS 2002 adr

USRDS Per member per month (PMPM) costs: EPO & iron figure 12. 22, period prevalent dialysis patients, 2000, by HSA, unadjusted PMPM (dollars) 568+ (623) 521 to <568 482 to <521 431 to <482 below 431 (389) USRDS 2002 adr

USRDS Per member per month (PMPM) costs: vitamin D hormones & other injectables figure 12. 22, period prevalent dialysis patients, 2000, by HSA, unadjusted PMPM (dollars) 149+ (175) 130 to <149 116 to <130 103 to <116 below 103 (85) USRDS 2002 adr

USRDS Per member per month (PMPM) costs: inpatient figure 12. 23, period prevalent dialysis patients, 2000, by HSA, unadjusted PMPM (dollars) 1, 400+ (1, 577) 1, 330 to <1, 400 1, 280 to <1, 330 1, 220 to <1, 280 below 1, 220 (1, 128) USRDS 2002 adr

USRDS Per member per month (PMPM) costs: outpatient figure 12. 23, period prevalent dialysis patients, 2000, by HSA, unadjusted PMPM (dollars) 2, 030+ (2, 093) 1, 990 to <2, 030 1, 950 to <1, 990 1, 900 to <1, 950 below 1, 900 (1, 833) USRDS 2002 adr

USRDS Per member per month (PMPM) Part A Costs: inpatient figure 12. 24, period prevalent dialysis patients, 2000, by HSA, unadjusted PMPM (dollars) 1, 400+ (1, 577) 1, 330 to <1, 400 1, 280 to <1, 330 1, 220 to <1, 280 below 1, 220 (1, 128) USRDS 2002 adr

USRDS Per member per month (PMPM) Part A Costs: outpatient figure 12. 24, period prevalent dialysis patients, 2000, by HSA, unadjusted PMPM (dollars) 921+ (987) 868 to <921 829 to <868 782 to <829 below 782 (738) USRDS 2002 adr

USRDS Per member per month (PMPM) Part A Costs: dialysis figure 12. 24 period prevalent dialysis patients, 2000, by HSA, unadjusted PMPM (dollars) 1, 150+ (1, 202) 1, 110 to <1, 150 1, 090 to <1, 110 1, 070 to <1, 090 below 1, 070 (1, 036) USRDS 2002 adr

USRDS Per member per month (PMPM), Part B costs figure 12. 24, period prevalent dialysis patients, 2000, by HSA, unadjusted PMPM (dollars) 868+ (964) 795 to <868 741 to <795 663 to <741 below 663 (601) USRDS 2002 adr

USRDS Part A relative costs: inpatient figure 12. 25, period prevalent patients, 2000, by HSA, adjusted for age, gender, race, & diabetic status Relative cost 1. 80+ (2. 51) 1. 20 to <1. 80 0. 81 to <1. 20 0. 44 to <0. 81 below 0. 44 (0. 26) USRDS 2002 adr

USRDS Part A relative costs: outpatient figure 12. 25, period prevalent patients, 2000, by HSA, adjusted for age, gender, race, & diabetic status Relative cost 1. 09+ (1. 16) 1. 03 to <1. 09 0. 98 to <1. 03 0. 92 to <0. 98 below 0. 92 (0. 84) USRDS 2002 adr

USRDS Part A relative costs: dialysis figure 12. 25, period prevalent patients, 2000, by HSA, adjusted for age, gender, race, & diabetic status Relative cost 1. 04+ (1. 09) 1. 01 to <1. 04 0. 99 to <1. 01 0. 96 to <0. 99 below 0. 96 (0. 90) USRDS 2002 adr

USRDS Part B relative costs figure 12. 25, period prevalent patients, 2000, by HSA, adjusted for age, gender, race, & diabetic status Relative cost 1. 13+ (1. 26) 1. 04 to <1. 13 0. 97 to <1. 04 0. 85 to <0. 97 below 0. 85 (0. 76) USRDS 2002 adr

USRDS Trends in total access procedures figure 12. 26, Medicare ESRD Part B vascular access claims identified by CPT codes USRDS 2002 adr

USRDS Trends in access costs figure 12. 27, Medicare ESRD Part B vascular access claims identified by CPT codes USRDS 2002 adr

USRDS Trends in location of access procedures figure 12. 28, by setting, Medicare Part B vascular access claims identified by CPT codes, location identified from CMS “place of service variable” USRDS 2002 adr

USRDS Percent of procedures that are access only figure 12. 29 USRDS 2002 adr

USRDS Vascular access spending: dollars by intervention type & location of service figure 12. 30 USRDS 2002 adr

USRDS Vascular access spending: dollars by access type & intervention figure 12. 31 USRDS 2002 adr

USRDS Vascular access spending: dollars by access type & physician specialty figure 12. 32 USRDS 2002 adr

USRDS Fistula insertion costs per procedure: 1991 figure 12. 33, by state Cost per procedure 9, 800+ (10, 756) 7, 450 to <9, 800 6, 440 to <7, 450 4, 710 to <6, 440 below 4, 710 (4, 379) USRDS 2002 adr

USRDS Fistula insertion costs per procedure: 2000 figure 12. 33, by state Cost per procedure 9, 800+ (11, 055) 7, 450 to <9, 800 6, 440 to <7, 450 4, 710 to <6, 440 below 4, 710 (3, 647) USRDS 2002 adr

USRDS Fistula insertion costs per procedure: percent change 1991– 2000 figure 12. 33, by state Percent change in costs, 1991 -2000 -30. 6+ (-3. 6) -46. 5 to <-30. 6 -72. 8 to <-46. 5 -125. 5 to <-72. 8 below -125. 5 (-180. 0) USRDS 2002 adr

USRDS Synthetic graft insertion costs per procedure: 1991 figure 12. 34, by state Cost per procedure 10, 800+ (12, 622) 9, 200 to <10, 800 7, 700 to <9, 200 7, 000 to <7, 700 below 7, 000 (6, 203) USRDS 2002 adr

USRDS Synthetic graft insertion costs per procedure: 2000 figure 12. 34, by state Cost per procedure 10, 800+ (12, 197) 9, 200 to <10, 800 7, 700 to <9, 200 7, 000 to <7, 700 below 7, 000 (5, 407) USRDS 2002 adr

USRDS Synthetic graft insertion costs per procedure: percent change 1991– 2000 figure 12. 34, by state Percent change in costs, 1991 -2000 -18. 9+ (-8. 6) -37. 3 to <-18. 9 -57. 1 to <-37. 3 -79. 2 to <-57. 1 below -79. 2 (-115. 4) USRDS 2002 adr

USRDS Catheter insertion costs per procedure: 1991 figure 12. 35, by state Cost per procedure 8, 760+ (10, 450) 7, 750 to <8, 760 6, 470 to <7, 570 5, 250 to <6, 470 below 5, 250 (4, 243) USRDS 2002 adr

USRDS Catheter insertion costs per procedure: 2000 figure 12. 35, by state Cost per procedure 8, 760+ (9, 679) 7, 750 to <8, 760 6, 470 to <7, 570 5, 250 to <6, 470 below 5, 250 (4, 074) USRDS 2002 adr

USRDS Catheter insertion costs per procedure: percent change 1991– 2000 figure 12. 35, by state Percent change in costs, 1991 -2000 -23. 4+ (-10. 9) -40. 0 to <-23. 4 -52. 4 to <-40. 0 -75. 9 to <-52. 4 below -75. 9 (-136. 7) USRDS 2002 adr

USRDS Vascular access complications costs per event: 1991 figure 12. 36, by state Cost 7, 530+ (8, 931) 5, 080 to <7, 530 2, 830 to <5, 080 2, 420 to <2, 830 below 2, 420 (N/A) USRDS 2002 adr

USRDS Vascular access complications costs per event: 2000 figure 12. 36, by state Cost 7, 530+ (NA) 5, 080 to <7, 530 2, 830 to <5, 080 2, 420 to <2, 830 below 2, 420 (1, 897) USRDS 2002 adr

USRDS Vascular access complications costs per event: percent change 1991– 2000 figure 12. 36, by state Percent change in costs, 1991 -2000 -117+ (-85) -159 to <-117 -210 to <-159 -247 to <-210 below -247 (-304) USRDS 2002 adr